The molecule MDMA (3,4-Methylenedioxymethamphetamine) has been used to treat post-traumatic stress disorder in a single dose. If you suffer from PTSD, mark your calendar. It is being fast-tracked by the FDA and is expected to be legal in ~2022.
“Posttraumatic stress disorder (PTSD) is a disabling and potentially life-threatening mental health condition that can be caused by one-time or ongoing events including discrimination and oppression, war, sexual assault, childhood abuse, torture, accidents, and other stressful events. People who suffer from PTSD often relive their traumatic experiences through nightmares and flashbacks, have difficulty sleeping, and feel detached or estranged. Symptoms can be severe and long-lasting, creating negative impacts on a person’s daily life and well-being.
When administered in a clinical setting with trained therapy providers, MDMA has proven to be a powerful adjunct to psychotherapy, which assists individuals in processing traumatic experiences in a deep and profound manner, leading to the alleviation of suffering. Clinical research indicates that MDMA may catalyze therapeutic processing by allowing participants to stay emotionally engaged when revisiting traumatic experiences, without feeling overwhelmed by anxiety or other painful emotions.”
—MAPS.org
Help Veterans and Victims of PTSD
Please donate to the matching grant at capstone.maps.org before September 10th 2020, or MAPS.org thereafter.